Gros David-Alexandre C 4
4 · Eledon Pharmaceuticals, Inc. · Filed Jan 13, 2025
Insider Transaction Report
Form 4
Gros David-Alexandre C
DirectorChief Executive Officer
Transactions
- AwardSwap
Restricted Stock Units
2025-01-10+66,500→ 66,500 total→ Common Stock (66,500 underlying) - Award
Stock Option (right to buy)
2025-01-10+600,000→ 600,000 totalExercise: $4.04Exp: 2035-01-10→ Common Stock (600,000 underlying)
Footnotes (3)
- [F1]This option represents a right to purchase up to 600,000 shares of common stock, which option vests with respect to 150,000 shares on January 10, 2026, and then with respect to 6.25% of the underlying shares quarterly over the three-year period ending January 10, 2029, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.
- [F2]Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's common stock upon settlement for no consideration.
- [F3]Represents shares issuable on settlement of restricted stock units ("RSUs"). The RSUs will vest with respect to 50% of the RSUs on January 10, 2027, and then with respect to the remaining 50% of the underlying shares on January 10 2028, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.